If you have had a sentinel node biopsy, your breast surgeon or oncologist may have mentioned micrometastases. They are extremely important in almost any type of cancer and are the reason behind adjuvant therapy—treatment given after surgery to help prevent a recurrence of cancer.
This article will review micrometastases in breast cancer and how they are diagnosed and treated.
Diagnosis
Micrometastases are defined as clusters of cancer cells that are between 0.2 millimeters and 2 millimeters (mm) in diameter. Any smaller clusters are called isolated tumor cells.
When cancer first spreads and forms micrometastases, the only way to detect them is to remove the tissue where they are located and look at slices under a microscope. This is known as a lymph node biopsy.
However, it’s impossible to remove and examine every lymph node and organ in the body to check for small cancer cells. Oncologists assume tiny, undetectable metastases may exist outside of the breast(s) and lymph nodes when:
A tumor is of a particular size. There’s evidence cancer has spread to the lymph nodes.
When there isn’t evidence of lymph node involvement on exam or ultrasound, a sentinel lymph node biopsy is done. In this procedure, blue dye is injected into the breast and allowed to travel so that it reaches the nearby lymph nodes. When cancer spreads from tumors, it often spreads to lymph nodes in a predictable pattern. The dye can help healthcare providers see that pattern and identify where to look for micrometastases.
By doing a biopsy of the sentinel node or nodes—the first few nodes that cancer would travel to—many women are spared a full axillary lymph node dissection (removal of many or all of the lymph nodes in the armpit). Since removing all the nodes can result in complications such as lymphedema, a sentinel node biopsy is considered a safer option.
Meanwhile, people who have isolated tumor cells in the sentinel node do not have a prognosis any worse than a person with no evidence of metastases to the sentinel node.
Having this information can help healthcare providers understand which patients will need a full axillary lymph node dissection, and which should consider adjuvant treatment of their breast cancer.
Treatment
Adjuvant chemotherapy or adjuvant radiation therapy are used after a primary tumor has been removed to “clean up” any micrometastases near the origin of the tumor (via radiation) or anywhere in the body where they may have traveled (via chemotherapy).
For hormone receptor positive disease, hormone treatments such as tamoxifen or letrozole can be as important as chemotherapy for treating metastases.
Which treatment you’ll need depends on where the metastases are believed to be. Your healthcare provider may recommend both chemotherapy and radiation, as well.
Breast cancers that have begun to travel to the lymph nodes are more likely to spread to other regions of the body. Therefore, it’s important to be aggressive with treatment.
Summary
Micrometastases are microscopic cancer cells that have escaped from the original tumor. These cells can be too small to see on imaging tests.
There are some characteristics of breast cancer, such as size and the presence of cancer in lymph nodes, that make micrometastasis more likely. A procedure called a sentinel node biopsy can help healthcare providers know where to look for micrometastases. They can be treated with chemotherapy or radiation.
